Galapagos NV
GLPG
#4540
Rank
C$3.03 B
Marketcap
C$46.12
Share price
-0.73%
Change (1 day)
36.25%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): C-$0.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.46. In 2024 the company made an earnings per share (EPS) of C$1.59 a decrease over its 2023 EPS that were of C$4.83.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.67-142.17%
2024C$1.59-67.16%
2023C$4.83-199.64%
2022C-$4.8599.03%
2021C-$2.44-68.98%
2020C-$7.85-298.06%
2019C$3.96-554.64%
2018C-$0.87-77.18%
2017C-$3.82-326.21%
2016C$1.69-134.19%
2015C-$4.94-371.34%
2014C$1.82-445.98%
2013C-$0.5332.88%
2012C-$0.40-82.07%
2011C-$2.21-817.9%
2010C$0.3112.73%
2009C$0.27-120.79%
2008C-$1.31-37.67%
2007C-$2.1139.64%
2006C-$1.5128.17%
2005C-$1.186.25%
2004C-$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$14.21-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.97-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.84-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.04-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.34-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$4.13-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$4.90-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C-$0.83 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.86-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel